The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Anti-Obesity Drug Market - Forecast from 2026 to 2031
US$ 3,950.00
The anti-obesity drug market, sustaining a 19.04% CAGR, is anticipated to reach USD 116.381 billion in 2031 from USD 40.898 billion in 2025. The anti-obesity drug market is positioned for steady growt...
January 2026
146 pages
Breast Cyst Treatment Market 2026
US$ 2,999.00
The Breast Cyst Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.08 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including region...
January 2026
200 pages
Atypical Hemolytic Uremic Syndrome Treatment Market 2026
US$ 2,999.00
The Atypical Hemolytic Uremic Syndrome Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dyna...
January 2026
200 pages
Acute On Chronic Liver Failure (ACLF) Market 2026
US$ 2,999.00
The Acute On Chronic Liver Failure (ACLF) Market was valued at in and is anticipated to reach by , at a CAGR of 0.06 from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...
January 2026
219 pages
Underactive Bladder Treatment Market 2026
US$ 2,999.00
The Underactive Bladder Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
January 2026
220 pages
Activated Carbon, Other Activated Natural Mineral Products, Animal Black: European Union Market Outlook 2026 and Forecast till 2030
US$ 1,800.00
... analysis of the European Union market for activated carbon, other activated natural mineral products, animal black, covering EU ... consumers of activated carbon, other activated natural mineral products, animal black are briefly overviewed as well. Activated Carbon, Other Activated Natural Mineral Products, ...
January 2026
40 pages
Antibiotics: European Union Market Outlook 2026 and Forecast till 2030
US$ 1,800.00
Antibiotics: European Union Market Outlook 2018 and Forecast till 2023 provides a complete overview of the market condition. All available data is presented in ... an in-depth analysis of the European Union market for antibiotics, covering EU total and local markets. It provides current statistics, historical ...
January 2026
40 pages
Antiphospholipid Syndrome (APS) Market - 2023-2031
US$ 2,999.00
The Antiphospholipid Syndrome (APS) Market was valued at US$ 32.87 billion in 2023 and is anticipated to reach US$ 68.43 billion by 2031, at a CAGR of 0.096 from 2026 to 2032. The report delivers in-d...
January 2026
210 pages
Barett Esophagus Treatment Market 2026
US$ 2,999.00
The Barett Esophagus Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including re...
January 2026
219 pages
Giant Cell Arteritis Drugs Market - 2023-2031
US$ 2,999.00
The Giant Cell Arteritis Drugs Market was valued at US$ 933.2 million in 2023 and is anticipated to reach US$ 1859.5 million by 2031, at a CAGR of 0.09 from 2026 to 2032. The report delivers in-depth...
January 2026
223 pages
Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report By Product (Viscosupplements, Bone Graft Substitutes, Adipose Tissue Therapy), By Application (Knee Osteoarthritis, Hip Osteoarthritis), By Primary User, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global osteoarthritis therapeutics market size was estimated at USD 5.49 billion in 2025 and is projected to reach USD 10.89 billion by 2033, growing at a CAGR of 8.88% from 2026 to 2033. The oste...
January 2026
150 pages
Acute Renal Failure Market - 2023-2031
US$ 2,999.00
The Acute Renal Failure Market was valued at US$ 5.30 million in 2023 and is anticipated to reach US$ 11.02 million by 2031, at a CAGR of 0.09 from 2026 to 2032. The report delivers in-depth insights...
January 2026
243 pages
Hypophosphatasia Treatment Market - 2023-2031
US$ 2,999.00
The Hypophosphatasia Treatment Market was valued at US$ 841.9 million in 2023 and is anticipated to reach US$ 2785.10 million by 2031, at a CAGR of 0.161 from 2026 to 2032. The report delivers in-dept...
January 2026
218 pages
